Powered by ZigaForm version 3.9.8.8

Public Alert No. 005/2020 – Alert on Falsified Chloroquine Products Circulating in WHO Region of Africa

April 13, 2020,

The National Agency for Food and Drugs Administration and Control (NAFDAC) has been informed by World Health Organization (WHO) that nine (9) confirmed falsified Chloroquine products are in circulation in the WHO region of Africa. Nine (9) reports of different confirmed falsified Chloroquine products from three African countries were received by WHO between 31st March and 2nd April, 2020. The three African Countries are Cameroon, Democratic Republic of Congo and Niger.

The details of the nine (9) identified falsified Chloroquine products are:

Identified

in

Product name Stated manufacturer Batch

number

Expiry

date

Date of of manufacture
Cameroon Chloroquine

Phosphate 100mg

Jiangsu Pharmaceutical

Inc.

660 05/2021 05/2017
Chloroquine

Phosphate 250mg

Jiangsu Pharmaceutical

Inc.

660 09/2022 09/2018
Chloroquine

Phosphate 250mg

Astral

Pharmaceuticals

EBT 2542 10/2022 01/2019
Democratic

Republic of

Congo

CLOROQUINE

250mg

Dawa Limited 1605059 04/2023 05/2019
Chloroquine

Phosphate

250mg

Brown &Burk

Pharmaceutical limited

065622 11/2022 11/2018
Niger Samquine100

(100mg)

None indicated NBJT01 Oct-2022 Nov-2019
Chloroquine

Phosphate

Tablets B.P

100mg

None indicated HV1116 May 2023 June 2019
Chloroquine

Phosphate

Tablets B.P

100mg

None indicated NBJT02 Oct-2022 Nov-2019
Niruquine 100mg None indicated Unknown 08/2022 09/2019

The nine (9) falsified Chloroquine products do not contain the correct amount of Active Pharmaceutical Ingredient (API). They were not manufactured by the manufacturers whose names are stated on the product labels.

The batch number, manufacturing and expiry dates on the falsified products do not correspond to genuine manufacturing records. The manufacturers whose names are stated on the falsified product labels do not exist.

The pictorial presentations of falsified Chloroquine products identified in  Cameroon are:

It should be noted that falsified Chloroquine Phosphate 250mg manufactured by Jiangsu Pharmaceutical Inc and Astral Pharmaceuticals circulating in Cameroon  were in Public Alert No. 004/2020 – Alert on Falsified Chloroquine Phosphate 250mg Tablets Circulating in Cameroon issued by NAFDAC on 4th April, 2020.

The pictorial presentations of falsified CLOROQUINE 250mg and Chloroquine Phosphate 250mg identified in  Democratic Republic of Congo are:

The pictorial presentations of falsified Chloroquine Phosphate 100mg identified in Niger are:

The use of falsified Chloroquine products may result in treatment failure and even death.

Genuine Chloroquine registered by NAFDAC is used for treatment of rheumatoid arthritis and extraintestinal amebiasis. 

All importers, wholesalers and retailers are implored to desist from illegal importation, distribution and sale of the falsified Chloroquine products. Any importer, wholesaler, retailer caught dealing with falsified chloroquine or any other falsified medicines will be severely sanctioned.

Surveillance has been strengthened by NAFDAC at all ports of entry to prevent illegal importation of the falsified Chloroquine products

The Agency has heightened surveillance in the thirty-six States and the Federal Capital Territory, Abuja to prevent distribution and sale of falsified Chloroquine products

Health care providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified Chloroquine products.

Anybody in possession of the falsified Chloroquine products should submit them to the nearest NAFDAC office.

Consumers are advised to report adverse events related to use of medicines to the nearest NAFDAC office, 0800-1-NAFDAC (0800-1-623322) TOLL FREE from all networks or via pharmacovigilance@nafdac.gov.ng

NAFDAC……..Customer-focused, Agency-minded!!!

Signed Management